MDD patients often have an elevated immune response [194] and pro-inflammatory factors [195] such as TNF-α [196], C-reactive protein (CRP), IL-6, and interleukin-1 receptor antagonist (IL-1ra) [197], while patients with somatic and inflammatory disorders have an increased risk of developing MDD [198]. This evidence concerns the gene IL6 and major depressive disorder.